Health CareHealth Care Equipment & Services
  • Price (AUD)132.73
  • Today's Change2.40 / 1.84%
  • Shares traded206.68k
  • 1 Year change46.19%
  • Beta1.0818
Data delayed at least 20 minutes, as of Jul 29 2016 07:10 BST.
More ▼

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Cochlear Ltd grew revenues 14.99% from 804.94m to 925.63m while net income improved 55.63% from 93.71m to 145.84m.
Gross margin69.95%
Net profit margin16.12%
Operating margin22.66%
Return on assets19.24%
Return on equity45.74%
Return on investment29.49%
More ▼

Cash flow in AUDView more

In 2015, Cochlear Ltd increased its cash reserves by 28.65%, or 16.08m. The company earned 188.70m from its operations for a Cash Flow Margin of 20.39%. In addition the company used 28.43m on investing activities and also paid 148.84m in financing cash flows.
Cash flow per share--
Price/Cash flow per share--
Book value per share7.26
Tangible book value per share3.16
More ▼

Balance sheet in AUDView more

Cochlear Ltd has a Debt to Total Capital ratio of 33.91%, a lower figure than the previous year's 70.75%.
Current ratio1.32
Quick ratio0.9381
Total debt/total equity0.5131
Total debt/total capital0.3391
More ▼

Growth rates in AUD

Year on year, growth in dividends per share fell -25.20% while earnings per share excluding extraordinary items rose 55.16%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)3.48%
Div growth rate (5 year)-1.02%
Payout ratio (TTM)67.80%
EPS growth(5 years)-1.4563
EPS (TTM) vs
TTM 1 year ago
16.71
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.